Healthcare provider profile · identity verified

William Frank Catrett, M.D.

Family Practice · BUENA VISTA, GA · NPI 1164518338

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	410	27
Gabapentin	Gabapentin	223	35
Omeprazole	Omeprazole	212	16
Metformin Hcl	Metformin Hcl	194	25
Lisinopril	Lisinopril	179	20
Mirtazapine	Mirtazapine	163	suppressed
Sertraline Hcl	Sertraline Hcl	159	suppressed
Potassium Chloride	Potassium Chloride	154	11
Clopidogrel	Clopidogrel Bisulfate	144	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	142	15
Memantine Hcl	Memantine Hcl	140	suppressed
Montelukast Sodium	Montelukast Sodium	132	26
Donepezil Hcl	Donepezil Hcl	131	suppressed
Atorvastatin Calcium	Atorvastatin Calcium	127	28
Carvedilol	Carvedilol	123	suppressed
Simvastatin	Simvastatin	122	14
Quetiapine Fumarate	Quetiapine Fumarate	120	suppressed
Metoprolol Succinate	Metoprolol Succinate	118	15
Amlodipine Besylate	Amlodipine Besylate	116	25
Eliquis	Apixaban	116	suppressed
Meloxicam	Meloxicam	112	17
Divalproex Sodium	Divalproex Sodium	103	suppressed
Prednisone	Prednisone	103	37
Metoprolol Tartrate	Metoprolol Tartrate	95	12
Carbamazepine	Carbamazepine	93	suppressed
Trazodone Hcl	Trazodone Hcl	90	suppressed
Spironolactone	Spironolactone	88	suppressed
Farxiga	Dapagliflozin Propanediol	87	suppressed
Citalopram Hbr	Citalopram Hydrobromide	86	14
Allopurinol	Allopurinol	84	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	77	13
Januvia	Sitagliptin Phosphate	74	suppressed
Losartan Potassium	Losartan Potassium	72	20
Hydralazine Hcl	Hydralazine Hcl	71	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	71	14
Oxybutynin Chloride	Oxybutynin Chloride	71	suppressed
Tramadol Hcl	Tramadol Hcl	68	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	67	16
Nifedipine Er	Nifedipine	66	suppressed
Baclofen	Baclofen	65	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	65	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	59	18
Dexamethasone	Dexamethasone	58	40
Paroxetine Hcl	Paroxetine Hcl	58	suppressed
Duloxetine Hcl	Duloxetine Hcl	57	suppressed
Bupropion Xl	Bupropion Hcl	56	suppressed
Levetiracetam	Levetiracetam	53	suppressed
Methimazole	Methimazole	53	suppressed
Olanzapine	Olanzapine	53	suppressed
Roflumilast	Roflumilast	53	suppressed
Aripiprazole	Aripiprazole	50	suppressed
Azithromycin	Azithromycin	42	32
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	32	28
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Colesevelam Hcl	Colesevelam Hcl	30	suppressed
Ibuprofen	Ibuprofen	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Febuxostat	Febuxostat	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	suppressed
Ozempic	Semaglutide	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Topiramate	Topiramate	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	20	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Mupirocin	Mupirocin	17	15
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Cephalexin	Cephalexin	14	11
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	13	suppressed
Atenolol	Atenolol	12	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	12	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error